Cargando…

Prostasin regulates PD-L1 expression in human lung cancer cells

The serine protease prostasin is a negative regulator of lipopolysaccharide-induced inflammation and has a role in the regulation of cellular immunity. Prostasin expression in cancer cells inhibits migration and metastasis, and reduces epithelial–mesenchymal transition. Programmed death-ligand 1 (PD...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Li-Mei, Chai, Julius C., Liu, Bin, Strutt, Tara M., McKinstry, K. Kai, Chai, Karl X.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Portland Press Ltd. 2021
Materias:	Cancer
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8273379/ https://www.ncbi.nlm.nih.gov/pubmed/34240739 http://dx.doi.org/10.1042/BSR20211370

Ejemplares similares

Ibuprofen regulates the expression and function of membrane-associated serine proteases prostasin and matriptase
por: Chai, Andreas C., et al.
Publicado: (2015)

Exosome-Mediated Activation of the Prostasin-Matriptase Serine Protease Cascade in B Lymphoma Cells
por: Chen, Li-Mei, et al.
Publicado: (2023)

Mouse Models Reveal Role of T-Cytotoxic and T-Reg Cells in Immune Response to Influenza: Implications for Vaccine Design
por: Sell, Stewart, et al.
Publicado: (2019)

Loss of prostasin (PRSS8) in human bladder transitional cell carcinoma cell lines is associated with epithelial-mesenchymal transition (EMT)
por: Chen, Li-Mei, et al.
Publicado: (2009)

Expanding roles for CD4(+) T cells in immunity to viruses
por: Swain, Susan L., et al.
Publicado: (2012)

T-bet optimizes CD4 T-cell responses against influenza through CXCR3-dependent lung trafficking but not functional programming
por: Dhume, Kunal, et al.
Publicado: (2019)

Prostasin: An Epithelial Sodium Channel Regulator
por: Aggarwal, Shakti, et al.
Publicado: (2013)

New Insights into the Generation of CD4 Memory May Shape Future Vaccine Strategies for Influenza
por: Devarajan, Priyadharshini, et al.
Publicado: (2016)

CD122-targetted IL-2 signals cause acute and selective apoptosis of B cells in Peyer’s Patches
por: Singh, Ayushi, et al.
Publicado: (2020)

Regulation of Adrenal Aldosterone Production by Serine Protease Prostasin
por: Ko, Takehiro, et al.
Publicado: (2010)

IL-15 supports the generation of protective lung-resident memory CD4 T cells
por: Strutt, Tara M., et al.
Publicado: (2017)

Expression of prostasin and its inhibitors during colorectal cancer carcinogenesis
por: Selzer-Plon, Joanna, et al.
Publicado: (2009)

Memory CD4 T cell-derived IL-2 synergizes with viral infection to exacerbate lung inflammation
por: McKinstry, K. Kai, et al.
Publicado: (2019)

Effector CD4 T cell transition to memory requires late cognate interactions that induce autocrine IL-2
por: McKinstry, K. Kai, et al.
Publicado: (2014)

Association between preeclampsia and prostasin polymorphism in Pakistani females
por: Ejaz, Saima, et al.
Publicado: (2020)

PD-L1 regulates tumorigenesis and autophagy of ovarian cancer by activating mTORC signaling
por: Gao, Hongmin, et al.
Publicado: (2019)

Prognostic significance of PD‐L2 expression in patients with oral squamous cell carcinoma—A comparison to the PD‐L1 expression profile
por: Weber, Manuel, et al.
Publicado: (2019)

PSP94, an upstream signaling mediator of prostasin found highly elevated in ovarian cancer
por: Ma, J-x, et al.
Publicado: (2014)

The serine protease prostasin regulates hepatic insulin sensitivity by modulating TLR4 signalling
por: Uchimura, Kohei, et al.
Publicado: (2014)

Genetic polymorphism of the prostasin gene in hypertensive pregnant Pakistani females
por: Ejaz, Saima, et al.
Publicado: (2021)

Determining the optimal PD‐1/PD‐L1 inhibitors for the first‐line treatment of non‐small‐cell lung cancer with high‐level PD‐L1 expression in China
por: Teng, Meng‐Meng, et al.
Publicado: (2021)

Baseline monocyte and its classical subtype may predict efficacy of PD-1/PD-L1 inhibitor in cancers
por: Shao, Yilin, et al.
Publicado: (2021)

Relationship of tumor PD‐L1 (CD274) expression with lower mortality in lung high‐grade neuroendocrine tumor
por: Inamura, Kentaro, et al.
Publicado: (2017)

Membrane protease prostasin promotes insulin secretion by regulating the epidermal growth factor receptor pathway
por: Ishii, Toshihisa, et al.
Publicado: (2023)

Regulation of CD4 T Cell Responses by the Transcription Factor Eomesodermin
por: Dhume, Kunal, et al.
Publicado: (2022)

PD‐1/PD‐L1 Blockade Therapy in Advanced Non‐Small‐Cell Lung Cancer: Current Status and Future Directions
por: Xia, Liliang, et al.
Publicado: (2019)

Conserved function of the matriptase-prostasin proteolytic cascade during epithelial morphogenesis
por: Drees, Leonard, et al.
Publicado: (2019)

The BRCA1 Methylation and PD-L1 Expression in Sporadic Ovarian Cancer
por: Zhu, Xinxin, et al.
Publicado: (2018)

A rapid blood test to monitor immunity shift during pregnancy and potential application for animal health management
por: Zheng, Tianyu, et al.
Publicado: (2020)

PD-L1 expression in anogenital and oropharyngeal squamous cell carcinomas associated with different clinicopathological features, HPV status and prognosis: a meta-analysis
por: Qin, Yuan, et al.
Publicado: (2021)

mTOR up-regulation of SNRPA1 contributes to hepatocellular carcinoma development
por: Feng, Jing, et al.
Publicado: (2020)

Prostasin, A Potential Tumor Marker in Ovarian Cancer- A Pilot Study
por: Costa, Fernanda Pires, et al.
Publicado: (2009)

Plasma prostasin: a novel risk marker for incidence of diabetes and cancer mortality
por: Bao, Xue, et al.
Publicado: (2022)

Ocular adverse events in PD-1 and PD-L1 inhibitors
por: Young, LeAnne, et al.
Publicado: (2021)

Remodeling of the tumor microenvironment using an engineered oncolytic vaccinia virus improves PD-L1 inhibition outcomes
por: Lou, Jiaying, et al.
Publicado: (2021)

Study and analysis of antitumor resistance mechanism of PD1/PD‐L1 immune checkpoint blocker
por: Wang, Zhengyi, et al.
Publicado: (2020)

Integration of comprehensive genomic profiling, tumor mutational burden, and PD‐L1 expression to identify novel biomarkers of immunotherapy in non‐small cell lung cancer
por: Shi, Yunfei, et al.
Publicado: (2021)

The landscape of immune microenvironment in lung adenocarcinoma and squamous cell carcinoma based on PD‐L1 expression and tumor‐infiltrating lymphocytes
por: Chen, Lu, et al.
Publicado: (2019)

Prognostic value of programmed cell death ligand 1 (PD-L1) for hepatocellular carcinoma: a meta-analysis
por: Li, Xiao-Song, et al.
Publicado: (2020)

Efficacy of PD-(L)1 blockade monotherapy compared with PD-(L)1 blockade plus chemotherapy in first-line PD-L1-positive advanced lung adenocarcinomas: a cohort study
por: Elkrief, Arielle, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_a5v84qsujdna08ee0uef4b5658